Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Recombinant Growth Hormone Therapy to Prevent Muscle Atrophy in Patients With Anterior Cruciate Ligament Tears

NCT02420353 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT02420353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02420353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Recombinant Growth Hormone Therapy to Prevent Muscle Atrophy in Patients With Anterior Cruciate Ligament Tears
Lead sponsor
University of Michigan
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2015
Completion date
October 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rupture of anterior cruciate ligament